A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults 50 Years Old and Older
Primary Purpose
Seasonal Influenza
Status
Active
Phase
Phase 3
Locations
International
Study Type
Interventional
Intervention
mRNA-1010
Licensed quadrivalent inactivated seasonal influenza vaccine
Sponsored by
About this trial
This is an interventional prevention trial for Seasonal Influenza focused on measuring Flu, Influenza, Vaccine, mRNA vaccine, mRNA-1010, Moderna
Eligibility Criteria
Inclusion Criteria:
Investigator has assessed that the participant understands and is willing and physically able to comply with protocol mandated follow-up, including all procedures.
- For female participants of childbearing potential: negative pregnancy test, adequate contraception or has abstained from all activities that could result in pregnancy for at least 28 days prior to the first dose on Day 1, and agreement to continue adequate contraception through 90 days following vaccine administration.
Exclusion Criteria:
- Participant has had close contact with someone with laboratory-confirmed influenza infection or with someone who has been treated with antiviral therapies for influenza (for example, Tamiflu®) within the past 5 days prior to the Screening visit.
- Participant has had close contact to someone with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or COVID-19 as defined by the US CDC or has had a positive SARS-CoV-2 test in the past 10 days prior to the Screening visit.
- Participant is acutely ill or febrile (temperature ≥38.0℃elcius [100.4°Fahrenheit]) 72 hours prior to or at the Screening visit or Day 1. Participants meeting this criterion may be rescheduled within the 28-day screening window.
- Participant has a history of a diagnosis or condition that, in the judgment of the investigator, is clinically unstable or may affect participant safety, assessment of safety endpoints, assessment of immune response, or adherence to study procedures.
- Reported history of congenital or acquired immunodeficiency, immunocompromising/ immunosuppressive condition, asplenia, or recurrent severe infections.
- Reported history of anaphylaxis or severe hypersensitivity reaction after receipt of any mRNA or influenza vaccines or any components of the mRNA or influenza vaccines, including egg protein.
- Participant has received systemic immunosuppressant drugs for >14 days in total within 180 days prior to the Screening visit (for glucocorticosteroids, ≥10 milligrams (mg)/day of prednisone or equivalent) or is anticipating the need for systemic immunosuppressive treatment at any time during participation in the study. Inhaled, nasal, and topical steroids are allowed.
- Participant has received any vaccine authorized or approved by local health agency ≤28 days prior to study intervention (Day 1) or plans to receive a vaccine authorized or approved by local health agency within 28 days before or after the study intervention.
- Participant is unaware whether they have received an influenza vaccine in the previous influenza season.
- Participant received a seasonal influenza vaccine or any other investigational influenza vaccine within 180 days prior to Day 1
- Participant has tested positive for influenza by local health authority-approved testing methods within 180 days prior to Day 1.
- Participant has donated ≥450 milliliters (mL) of blood products within 28 days prior to the Screening visit or plans to donate blood products during the study.
Note: Other inclusion and exclusion criteria may apply.
Sites / Locations
- North Alabama Research Center, LLC
- Lenzmeier Family Medicine
- CCT Research
- Fiel Family and Sports Medicine/CCT Research
- Noble Clinical Research
- Lynn Institute of the Ozarks
- Baptist Health Center for Clinical Research
- Velocity Clinical Research, Banning
- Hope Clinical Research, LLC
- Marvel Clinical Research
- Velocity Clinical Research, Chula Vista
- Velocity Clinical Research, San Diego
- Velocity Clinical Research - Westlake
- Empire Clinical Research
- Artemis Institute for Clinical Research
- Benchmark Research-Texas
- Peninsula Research Associates (PRA)
- Artemis Institute for Clinical Research
- Women's Health Care Research Corp.
- Acclaim Clinical Research
- Medical Center for Clinical Research
- Shawn K Hassler MD
- West Coast Research LLC
- Velocity Clinical Research, Denver
- Arthritis & Rheumatology - Clinic of Northern Colorado
- Longmont Medical Research Network
- Nature Coast Clinical Research, LLC - Crystal River
- Floridian Clinical Research
- Homestead Associates in Research,Inc
- Broward Research Group
- Citrus Cardiology Consultants
- Encore Research Group-Jacksonville Center for Clinical Resea
- Health Awareness, Inc
- Multi-Therapeutic Research Associates, Inc.
- Accel Research Sites - Lakeland
- ARS - Meridien Research
- Global Health Research Center
- South Florida Research Center, Inc.
- Suncoast Research Associates Trials, LLC
- Miami centre of clinical research
- Clinical Trials of Florida, LLC
- Innovation Medical Research Center,inc
- New Tampa Health, Inc
- Tekton Research, Inc.
- Southeast Regional Research Group
- iResearch Atlanta, LLC
- In-Quest Medical Research
- Mount Vernon Clinical Research
- Meridian Clinical Research - Savannah
- Clinical Research Atlanta
- Velocity Clinical Research - Boise
- Great Lakes Clinical Trials LLC
- Great Lakes Clinical Trials LLC
- Great Lakes Clinical Trials LLC
- Chicago Health Medical Group
- Velocity Clinical Research - Valparaiso
- Meridian Clinical Research - Dakota Dunes
- Johnson County Clin-Trials (JCCT)
- Heartland Research Associates LLC
- Alliance for Multispecialty Research
- Meridian Clinical Research
- MedPharmics
- Medpharmics, LLC
- Nathan H Fischman MD LLC
- Privia Medical Group
- Rockville Internal Medicine Group
- Delricht Research
- DM Clinical Research - Detroit
- Paul G Matherne MD
- DELRICHT RESEARCH at GULFPORT MEMORIAL
- Sundance Clinical Research, LLC
- National Medical University and Embryonic Tissues Center EmC
- Montana Medical Research, Inc
- CCT Research at Skyline Medical Center, PC
- CCT Research / Methodist Physicians Clinic, Prairie Fields Family Medicine, PC
- Meridian Clinical Research
- Be Well Clinical Studies, LLC
- Medpace, Inc. - Clinical Pharmacology Unit (CPU)
- Meridian Clinical Research
- Papillon Research Centre
- Meridian Clinical Research - Omaha
- Midwest Regional Health Services, LLC/CCT Research
- CCT Research
- Clinical Research Center of Nevada LLC
- Santa Rosa Medical Centers of Nevada/ CCT Research
- Las Vegas Clinical Trials, LLC
- United Medical Associates
- Rochester Clinical Research, Inc
- Velocity Clinical Research - Syracuse
- Tryon Medical Group
- Carolina Institute for Clinical Research
- Diabetes & Endocrinology Consultants
- M3 Wake Research, Inc.
- PMG Research of Wilmington
- Trial Management Associates
- Wake Forest Baptist Medical Center
- Radiant Research
- Sterling Research Group
- CTI Clinical Research Center
- Velocity Clinical Research - Cincinnati
- Lynn Health Science Institute
- Delricht Research Tulsa
- Platinum Research Network, LLC
- Velocity Clinical Research - Grants Pass
- Velocity Clinical Resarch - Medford
- Velocity Clinical Research - Providence
- Velocity Clinical Research, Greenville
- Velocity Clinical Research - Columbia
- Velocity Clinical Research, Gaffney
- Velocity Clinical Research - Greenville
- Carolina Health Specialists
- Spartanburg Regional Health Services
- Black Hills Center for American Indian Health
- Delricht Research
- Tekton Research, Inc
- Platinum Research Network, LLC
- Zenos Clinical Research
- Benchmark Research
- DM Clinical Research
- Texas Center for Drug Development, Inc.
- DELRICHT RESEARCH at ZOMNIR FAMILY MEDICINE
- Research Your Health
- Epic Medical Research, LLC
- Clinical Trials of Texas, Inc
- DM Clinical Research
- Breco Research - A Tarheel Clinical Research Site
- Cope Family Medicine
- Olympus Family Medicine/CCT Research
- CenExel - JBR
- South Ogden Family Medicine clinic/CCT
- Velocity Clinical Research - Salt Lake City
- Meridian Clinical Research
- Clinical Research Partners, LLC
- Lakeview Medical Center
- MHAT Sveti Ivan Rilski
- MC City Clinic Sveti Georgi - Montana
- MHAT "Dr. Stamen Iliev
- Medical Center Medconsult Pleven
- Military Medical Academy
- SHAT of Pneumo-phthisiatric diseases - Sofia District
- Aggarwal and Associates LTD
- Aviva Clinical Trials Group Inc
- Hamilton Medical Research Group
- Okanagan Clinical Trials
- Centricity Research Quebec City
- Milestone Research Inc.
- Yang Medicine
- LMC Manna
- DIEX Research Quebec Inc.
- DIEX Research Quebec Inc.
- Alpha Recherche Clinique Inc
- Clinique de Lebourgneuf
- Clinique spécialisée en allergie - Allergy/Immunology/Asthma/Mpoc
- Diex Research Sherbrooke Inc
- Central Alberta Research Clinic
- Diex Recherche - Joilette - HyperCore - PPDS
- Glencar Medical Inc.
- Canadian Phase Onward Inc.
- LMC
- Manna Research
- Medicine Professional Corporation
- Toronto Western Hospital
- Diex Recherche Trois-Rivières
- Colchester East Hants Health Authority - Colchester Regional
- Diex Recherche Victoriaville
- Odense University Hospital
- Sjællands UniHosp, Roskilde - Medicine and Infectious Diseases
- Aarhus Universitetshospital
- Center for Clinical and Basic Research
- Innomedica OÜ
- Merelahe Family Doctors Centre
- Clinical Research Center
- Berliner Centrum für Reise- und Tropenmedizin
- Emovis GmbH
- Klinische Forschung Berlin-Mitte GmbH
- Klinische Forschung Berlin
- Klinische Forschung Dresden GmbH
- Medizentrum Essen Borbeck
- Studienzentrum Dr. Keller
- IKF Pneumologie
- Infektiologikum Frankfurt-Sachsenhausen
- Clinical Research Hamburg GmbH
- Klinische Forschung Hamburg GmbH
- Klinische Forschung Hannover-Mitte GmbH
- Siteworks GmbH
- Siteworks GmbH
- University Hospital Cologne AöR
- Synexus Clinical Research GmbH
- Praxis Illies
- Dermatologie Quist
- Praxis Schaum
- Klinische Forschung Schwerin GmbH
- Hautarztpraxis Leitz & Kollegen
- Studienzentrum Brinkum
- Leids Universitair Medisch Centrum (LUMC)
- Universitair Medisch Centrum (UMC) Utrecht - Julius Center for Health Sciences and Primary Care
- Centrum Medyczne Pratia Bydgoszcz
- Centrum Medyczne Plejady
- Krakowskie Centrum Medyczne Sp. z o.o.
- Centrum Medyczne AMED Oddzial w Lodzi
- ETG Lublin
- KO-MED Centra Kliniczne Lublin II
- ETG Skierniewice
- Centrum Innowacyjnych Terapii Sp. z o.o.
- Provita Centrum Medyczne Sp. z o.o.
- RCMed
- ETG Zamosc
- KO-MED Centra Kliniczne Sp. z o.o.
- Hospital de Antequera
- Hospital Clinic De Barcelona
- Hospital Santa Creu i Sant Pau - Research institut
- Universitat Autonoma de Barcelona (UAB) - Institut d'Investigacio en Atencio Primaria Jordi Gol (IDIAP Jordi Gol)
- Hospital Alvaro Cunqueiro
- Hospital Povisa
- Kaohsiung Veterans General Hospital
- China Medical University Hospital - division of Rheumatology - Taichung
- National Cheng Kung University hospital
- National Taiwan University Hospital - Family Medicine
- Taipei Medical University - Taipei Medical University Hospital
- Taipei Medical University - WanFang Hospital
- Tri-Service General Hospital - Neihu Branch - Infectious Diseases
- Royal United Hospital
- Layton Medical Centre
- Hull University Teaching Hospitals NHS Foundation trust
- University Hospitals of Leicester-Leicester Royal Hospital
- Liverpool University Hospitals NHS Foundation Trust - Aintree University Hospital (Fazakerley Hospital)
- GST NHS Found
- Newcastle University - Institute of Cellular Medicine (ICM)
- Panthera Biopartners - Manchester - multispeciality
- Panthera Biopartners - Sheffield - multispeciality
- Panthera Biopartners - Preston - multispeciality
- Southampton General Hospital
- Royal Cornwall Hospitals Trust - Respiratory
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
mRNA-1010
Licensed Quadrivalent Inactivated Seasonal Influenza Vaccine
Arm Description
Participants will receive a single dose of mRNA-1010 by intramuscular (IM) injection on Day 1.
Participants will receive a single dose of licensed quadrivalent inactivated seasonal influenza vaccine by IM injection on Day 1.
Outcomes
Primary Outcome Measures
Number of Participants with Solicited Local and Systemic Reactogenicity Adverse Reactions (ARs)
Number of Participants with Unsolicited Adverse Events (AEs)
Number of Participants with Serious Adverse Events (SAEs), Adverse Events of Special Interest (AESIs), Medically Attended Adverse Events (MAAEs), and AEs Leading to Discontinuation
Time to First Episode of Reverse Transcription Polymerase Chain Reaction (RT-PCR) Confirmed Protocol-Defined Influenza-Like Illness (ILI) Caused by Any Influenza A or B Virus Strains
Secondary Outcome Measures
Time to First Episode of RT-PCR Confirmed Protocol-Defined ILI Caused by Any Influenza A or B Virus Strains with Similarity to the Vaccine Strains
Similarity to strains selected for the seasonal vaccine will be determined by antigenicity testing and/or genomic sequencing.
Time to First Episode of RT-PCR Confirmed Protocol-Defined ILI Caused by Any Influenza A or B Virus Strains Antigenically Matched to the Vaccine Strains
Antigenically matched to strains selected for the seasonal vaccine will be determined by antigenicity testing.
Time to First Episode of RT-PCR Confirmed United States (US) Centers for Disease Control and Prevention (CDC)-Defined ILI Caused by Any Influenza A or B Virus Strains
Any strains include any influenza A or B strains, influenza A or B strains with similarity to vaccine strains and influenza A or B strains that are antigenically matched to vaccine strains. Antigenically matched to strains selected for the seasonal vaccine will be determined by antigenicity testing.
Time to First Episode of Culture-Confirmed Protocol-Defined ILI Caused by Any Influenza A or B
Any influenza A or B strains regardless of antigenic match to strains selected for the seasonal vaccine.
A positive result for influenza infection by viral culture is needed, following a positive result for influenza infection by RT-PCR.
Time to First Episode of Culture-Confirmed CDC-Defined ILI Caused by Any Influenza A or B
Any influenza A or B strains regardless of antigenic match to strains selected for the seasonal vaccine.
A positive result for influenza infection by viral culture is needed, following a positive result for influenza infection by RT-PCR
Number of Participants With Hospitalizations Associated With RT-PCR Confirmed Protocol-Defined ILI
Geometric Mean Titer (GMT) as Measured by Hemagglutination Inhibition (HAI) Assay
Number of Participants Reaching Seroconversion as measured by HAI Assay
Seroconversion is defined as either a prevaccination HAI titer <1:10 and a postvaccination titer ≥1:40 or a prevaccination HAI titer ≥1:10 and a minimum 4-fold rise in postvaccination HAI antibody titer.
Number of Participants with a Titer ≥1:40 as Measured by HAI Assay
Change from Baseline in Geometric Mean Fold Rise (GMFR) at Day 29 as Measured by HAI Assay
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05566639
Brief Title
A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults 50 Years Old and Older
Official Title
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older
Study Type
Interventional
2. Study Status
Record Verification Date
September 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
September 14, 2022 (Actual)
Primary Completion Date
January 10, 2024 (Anticipated)
Study Completion Date
January 10, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
ModernaTX, Inc.
4. Oversight
Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
The purpose of this study is to evaluate the safety and efficacy of mRNA-1010 in preventing seasonal influenza in adults 50 years and older.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Seasonal Influenza
Keywords
Flu, Influenza, Vaccine, mRNA vaccine, mRNA-1010, Moderna
7. Study Design
Primary Purpose
Prevention
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
22510 (Actual)
8. Arms, Groups, and Interventions
Arm Title
mRNA-1010
Arm Type
Experimental
Arm Description
Participants will receive a single dose of mRNA-1010 by intramuscular (IM) injection on Day 1.
Arm Title
Licensed Quadrivalent Inactivated Seasonal Influenza Vaccine
Arm Type
Active Comparator
Arm Description
Participants will receive a single dose of licensed quadrivalent inactivated seasonal influenza vaccine by IM injection on Day 1.
Intervention Type
Biological
Intervention Name(s)
mRNA-1010
Other Intervention Name(s)
Seasonal influenza vaccine
Intervention Description
Sterile liquid for injection
Intervention Type
Biological
Intervention Name(s)
Licensed quadrivalent inactivated seasonal influenza vaccine
Other Intervention Name(s)
Fluarix Tetra
Intervention Description
Sterile suspension for injection.
Primary Outcome Measure Information:
Title
Number of Participants with Solicited Local and Systemic Reactogenicity Adverse Reactions (ARs)
Time Frame
Up to Day 7 (7 days after vaccination)
Title
Number of Participants with Unsolicited Adverse Events (AEs)
Time Frame
Up to Day 28 (28 days after vaccination)
Title
Number of Participants with Serious Adverse Events (SAEs), Adverse Events of Special Interest (AESIs), Medically Attended Adverse Events (MAAEs), and AEs Leading to Discontinuation
Time Frame
Day 1 through Day 361
Title
Time to First Episode of Reverse Transcription Polymerase Chain Reaction (RT-PCR) Confirmed Protocol-Defined Influenza-Like Illness (ILI) Caused by Any Influenza A or B Virus Strains
Time Frame
14 days post-vaccination through Day 181 or end of influenza season, whichever ends later
Secondary Outcome Measure Information:
Title
Time to First Episode of RT-PCR Confirmed Protocol-Defined ILI Caused by Any Influenza A or B Virus Strains with Similarity to the Vaccine Strains
Description
Similarity to strains selected for the seasonal vaccine will be determined by antigenicity testing and/or genomic sequencing.
Time Frame
14 days post-vaccination through Day 181 or end of influenza season, whichever ends later
Title
Time to First Episode of RT-PCR Confirmed Protocol-Defined ILI Caused by Any Influenza A or B Virus Strains Antigenically Matched to the Vaccine Strains
Description
Antigenically matched to strains selected for the seasonal vaccine will be determined by antigenicity testing.
Time Frame
14 days post-vaccination through Day 181 or end of influenza season, whichever ends later
Title
Time to First Episode of RT-PCR Confirmed United States (US) Centers for Disease Control and Prevention (CDC)-Defined ILI Caused by Any Influenza A or B Virus Strains
Description
Any strains include any influenza A or B strains, influenza A or B strains with similarity to vaccine strains and influenza A or B strains that are antigenically matched to vaccine strains. Antigenically matched to strains selected for the seasonal vaccine will be determined by antigenicity testing.
Time Frame
14 days post-vaccination through Day 181 or end of influenza season, whichever ends later
Title
Time to First Episode of Culture-Confirmed Protocol-Defined ILI Caused by Any Influenza A or B
Description
Any influenza A or B strains regardless of antigenic match to strains selected for the seasonal vaccine.
A positive result for influenza infection by viral culture is needed, following a positive result for influenza infection by RT-PCR.
Time Frame
14 days post-vaccination through Day 181 or end of influenza season, whichever ends later
Title
Time to First Episode of Culture-Confirmed CDC-Defined ILI Caused by Any Influenza A or B
Description
Any influenza A or B strains regardless of antigenic match to strains selected for the seasonal vaccine.
A positive result for influenza infection by viral culture is needed, following a positive result for influenza infection by RT-PCR
Time Frame
14 days post-vaccination through Day 181 or end of influenza season, whichever ends later
Title
Number of Participants With Hospitalizations Associated With RT-PCR Confirmed Protocol-Defined ILI
Time Frame
14 days post-vaccination through Day 181 or end of influenza season, whichever ends later
Title
Geometric Mean Titer (GMT) as Measured by Hemagglutination Inhibition (HAI) Assay
Time Frame
Day 29
Title
Number of Participants Reaching Seroconversion as measured by HAI Assay
Description
Seroconversion is defined as either a prevaccination HAI titer <1:10 and a postvaccination titer ≥1:40 or a prevaccination HAI titer ≥1:10 and a minimum 4-fold rise in postvaccination HAI antibody titer.
Time Frame
Day 29
Title
Number of Participants with a Titer ≥1:40 as Measured by HAI Assay
Time Frame
Day 29
Title
Change from Baseline in Geometric Mean Fold Rise (GMFR) at Day 29 as Measured by HAI Assay
Time Frame
Baseline, Day 29
10. Eligibility
Sex
All
Minimum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Investigator has assessed that the participant understands and is willing and physically able to comply with protocol mandated follow-up, including all procedures.
For female participants of childbearing potential: negative pregnancy test, adequate contraception or has abstained from all activities that could result in pregnancy for at least 28 days prior to the first dose on Day 1, and agreement to continue adequate contraception through 90 days following vaccine administration.
Exclusion Criteria:
Participant has had close contact with someone with laboratory-confirmed influenza infection or with someone who has been treated with antiviral therapies for influenza (for example, Tamiflu®) within the past 5 days prior to the Screening visit.
Participant has had close contact to someone with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or COVID-19 as defined by the US CDC or has had a positive SARS-CoV-2 test in the past 10 days prior to the Screening visit.
Participant is acutely ill or febrile (temperature ≥38.0℃elcius [100.4°Fahrenheit]) 72 hours prior to or at the Screening visit or Day 1. Participants meeting this criterion may be rescheduled within the 28-day screening window.
Participant has a history of a diagnosis or condition that, in the judgment of the investigator, is clinically unstable or may affect participant safety, assessment of safety endpoints, assessment of immune response, or adherence to study procedures.
Reported history of congenital or acquired immunodeficiency, immunocompromising/ immunosuppressive condition, asplenia, or recurrent severe infections.
Reported history of anaphylaxis or severe hypersensitivity reaction after receipt of any mRNA or influenza vaccines or any components of the mRNA or influenza vaccines, including egg protein.
Participant has received systemic immunosuppressant drugs for >14 days in total within 180 days prior to the Screening visit (for glucocorticosteroids, ≥10 milligrams (mg)/day of prednisone or equivalent) or is anticipating the need for systemic immunosuppressive treatment at any time during participation in the study. Inhaled, nasal, and topical steroids are allowed.
Participant has received any vaccine authorized or approved by local health agency ≤28 days prior to study intervention (Day 1) or plans to receive a vaccine authorized or approved by local health agency within 28 days before or after the study intervention.
Participant is unaware whether they have received an influenza vaccine in the previous influenza season.
Participant received a seasonal influenza vaccine or any other investigational influenza vaccine within 180 days prior to Day 1
Participant has tested positive for influenza by local health authority-approved testing methods within 180 days prior to Day 1.
Participant has donated ≥450 milliliters (mL) of blood products within 28 days prior to the Screening visit or plans to donate blood products during the study.
Note: Other inclusion and exclusion criteria may apply.
Facility Information:
Facility Name
North Alabama Research Center, LLC
City
Athens
State/Province
Alabama
ZIP/Postal Code
35611
Country
United States
Facility Name
Lenzmeier Family Medicine
City
Glendale
State/Province
Arizona
ZIP/Postal Code
85308
Country
United States
Facility Name
CCT Research
City
Phoenix
State/Province
Arizona
ZIP/Postal Code
85044
Country
United States
Facility Name
Fiel Family and Sports Medicine/CCT Research
City
Tempe
State/Province
Arizona
ZIP/Postal Code
85283
Country
United States
Facility Name
Noble Clinical Research
City
Tucson
State/Province
Arizona
ZIP/Postal Code
85712
Country
United States
Facility Name
Lynn Institute of the Ozarks
City
Little Rock
State/Province
Arkansas
ZIP/Postal Code
72204
Country
United States
Facility Name
Baptist Health Center for Clinical Research
City
Little Rock
State/Province
Arkansas
ZIP/Postal Code
72205
Country
United States
Facility Name
Velocity Clinical Research, Banning
City
Banning
State/Province
California
ZIP/Postal Code
92220
Country
United States
Facility Name
Hope Clinical Research, LLC
City
Canoga Park
State/Province
California
ZIP/Postal Code
91303
Country
United States
Facility Name
Marvel Clinical Research
City
Huntington Beach
State/Province
California
ZIP/Postal Code
92647
Country
United States
Facility Name
Velocity Clinical Research, Chula Vista
City
La Mesa
State/Province
California
ZIP/Postal Code
91942
Country
United States
Facility Name
Velocity Clinical Research, San Diego
City
La Mesa
State/Province
California
ZIP/Postal Code
91942
Country
United States
Facility Name
Velocity Clinical Research - Westlake
City
Los Angeles
State/Province
California
ZIP/Postal Code
90057
Country
United States
Facility Name
Empire Clinical Research
City
Pomona
State/Province
California
ZIP/Postal Code
91767
Country
United States
Facility Name
Artemis Institute for Clinical Research
City
Riverside
State/Province
California
ZIP/Postal Code
92503
Country
United States
Facility Name
Benchmark Research-Texas
City
Riverside
State/Province
California
ZIP/Postal Code
92504-3206
Country
United States
Facility Name
Peninsula Research Associates (PRA)
City
Rolling Hills Estates
State/Province
California
ZIP/Postal Code
90274
Country
United States
Facility Name
Artemis Institute for Clinical Research
City
San Diego
State/Province
California
ZIP/Postal Code
92103
Country
United States
Facility Name
Women's Health Care Research Corp.
City
San Diego
State/Province
California
ZIP/Postal Code
92111
Country
United States
Facility Name
Acclaim Clinical Research
City
San Diego
State/Province
California
ZIP/Postal Code
92120
Country
United States
Facility Name
Medical Center for Clinical Research
City
San Diego
State/Province
California
ZIP/Postal Code
92120
Country
United States
Facility Name
Shawn K Hassler MD
City
San Francisco
State/Province
California
ZIP/Postal Code
94102-3014
Country
United States
Facility Name
West Coast Research LLC
City
San Ramon
State/Province
California
ZIP/Postal Code
94582
Country
United States
Facility Name
Velocity Clinical Research, Denver
City
Denver
State/Province
Colorado
ZIP/Postal Code
80209
Country
United States
Facility Name
Arthritis & Rheumatology - Clinic of Northern Colorado
City
Fort Collins
State/Province
Colorado
ZIP/Postal Code
80528
Country
United States
Facility Name
Longmont Medical Research Network
City
Longmont
State/Province
Colorado
ZIP/Postal Code
80501
Country
United States
Facility Name
Nature Coast Clinical Research, LLC - Crystal River
City
Crystal River
State/Province
Florida
ZIP/Postal Code
34429
Country
United States
Facility Name
Floridian Clinical Research
City
Hialeah
State/Province
Florida
ZIP/Postal Code
33016
Country
United States
Facility Name
Homestead Associates in Research,Inc
City
Hialeah
State/Province
Florida
ZIP/Postal Code
33016
Country
United States
Facility Name
Broward Research Group
City
Hollywood
State/Province
Florida
ZIP/Postal Code
33024
Country
United States
Facility Name
Citrus Cardiology Consultants
City
Inverness
State/Province
Florida
ZIP/Postal Code
34452
Country
United States
Facility Name
Encore Research Group-Jacksonville Center for Clinical Resea
City
Jacksonville
State/Province
Florida
ZIP/Postal Code
32216
Country
United States
Facility Name
Health Awareness, Inc
City
Jupiter
State/Province
Florida
ZIP/Postal Code
33458
Country
United States
Facility Name
Multi-Therapeutic Research Associates, Inc.
City
Lake City
State/Province
Florida
ZIP/Postal Code
32055
Country
United States
Facility Name
Accel Research Sites - Lakeland
City
Lakeland
State/Province
Florida
ZIP/Postal Code
33805
Country
United States
Facility Name
ARS - Meridien Research
City
Maitland
State/Province
Florida
ZIP/Postal Code
32751
Country
United States
Facility Name
Global Health Research Center
City
Miami Lakes
State/Province
Florida
ZIP/Postal Code
33016
Country
United States
Facility Name
South Florida Research Center, Inc.
City
Miami
State/Province
Florida
ZIP/Postal Code
33135
Country
United States
Facility Name
Suncoast Research Associates Trials, LLC
City
Miami
State/Province
Florida
ZIP/Postal Code
33135
Country
United States
Facility Name
Miami centre of clinical research
City
Miami
State/Province
Florida
ZIP/Postal Code
33155
Country
United States
Facility Name
Clinical Trials of Florida, LLC
City
Miami
State/Province
Florida
ZIP/Postal Code
33186
Country
United States
Facility Name
Innovation Medical Research Center,inc
City
Palmetto Bay
State/Province
Florida
ZIP/Postal Code
33157
Country
United States
Facility Name
New Tampa Health, Inc
City
Tampa
State/Province
Florida
ZIP/Postal Code
33603
Country
United States
Facility Name
Tekton Research, Inc.
City
Chamblee
State/Province
Georgia
ZIP/Postal Code
30341
Country
United States
Facility Name
Southeast Regional Research Group
City
Columbus
State/Province
Georgia
ZIP/Postal Code
31904
Country
United States
Facility Name
iResearch Atlanta, LLC
City
Decatur
State/Province
Georgia
ZIP/Postal Code
30030
Country
United States
Facility Name
In-Quest Medical Research
City
Norcross
State/Province
Georgia
ZIP/Postal Code
30092-4544
Country
United States
Facility Name
Mount Vernon Clinical Research
City
Sandy Springs
State/Province
Georgia
ZIP/Postal Code
30328
Country
United States
Facility Name
Meridian Clinical Research - Savannah
City
Savannah
State/Province
Georgia
ZIP/Postal Code
31406-2675
Country
United States
Facility Name
Clinical Research Atlanta
City
Stockbridge
State/Province
Georgia
ZIP/Postal Code
30281-9054
Country
United States
Facility Name
Velocity Clinical Research - Boise
City
Meridian
State/Province
Idaho
ZIP/Postal Code
83642
Country
United States
Facility Name
Great Lakes Clinical Trials LLC
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60625
Country
United States
Facility Name
Great Lakes Clinical Trials LLC
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60640
Country
United States
Facility Name
Great Lakes Clinical Trials LLC
City
Gurnee
State/Province
Illinois
ZIP/Postal Code
60031
Country
United States
Facility Name
Chicago Health Medical Group
City
River Forest
State/Province
Illinois
ZIP/Postal Code
60305
Country
United States
Facility Name
Velocity Clinical Research - Valparaiso
City
Valparaiso
State/Province
Indiana
ZIP/Postal Code
46385
Country
United States
Facility Name
Meridian Clinical Research - Dakota Dunes
City
Sioux City
State/Province
Iowa
ZIP/Postal Code
51106
Country
United States
Facility Name
Johnson County Clin-Trials (JCCT)
City
Lenexa
State/Province
Kansas
ZIP/Postal Code
66219
Country
United States
Facility Name
Heartland Research Associates LLC
City
Newton
State/Province
Kansas
ZIP/Postal Code
67114-9017
Country
United States
Facility Name
Alliance for Multispecialty Research
City
Wichita
State/Province
Kansas
ZIP/Postal Code
67207
Country
United States
Facility Name
Meridian Clinical Research
City
Baton Rouge
State/Province
Louisiana
ZIP/Postal Code
70809
Country
United States
Facility Name
MedPharmics
City
Covington
State/Province
Louisiana
ZIP/Postal Code
70433
Country
United States
Facility Name
Medpharmics, LLC
City
Metairie
State/Province
Louisiana
ZIP/Postal Code
70006
Country
United States
Facility Name
Nathan H Fischman MD LLC
City
New Orleans
State/Province
Louisiana
ZIP/Postal Code
70124
Country
United States
Facility Name
Privia Medical Group
City
Annapolis
State/Province
Maryland
ZIP/Postal Code
21401
Country
United States
Facility Name
Rockville Internal Medicine Group
City
Rockville
State/Province
Maryland
ZIP/Postal Code
20854-2957
Country
United States
Facility Name
Delricht Research
City
Springfield
State/Province
Massachusetts
ZIP/Postal Code
65807-7303
Country
United States
Facility Name
DM Clinical Research - Detroit
City
Southfield
State/Province
Michigan
ZIP/Postal Code
48076
Country
United States
Facility Name
Paul G Matherne MD
City
Biloxi
State/Province
Mississippi
ZIP/Postal Code
39531
Country
United States
Facility Name
DELRICHT RESEARCH at GULFPORT MEMORIAL
City
Gulfport
State/Province
Mississippi
ZIP/Postal Code
39503
Country
United States
Facility Name
Sundance Clinical Research, LLC
City
Saint Louis
State/Province
Missouri
ZIP/Postal Code
63141
Country
United States
Facility Name
National Medical University and Embryonic Tissues Center EmC
City
Springfield
State/Province
Missouri
ZIP/Postal Code
65802
Country
United States
Facility Name
Montana Medical Research, Inc
City
Missoula
State/Province
Montana
ZIP/Postal Code
59808
Country
United States
Facility Name
CCT Research at Skyline Medical Center, PC
City
Elkhorn
State/Province
Nebraska
ZIP/Postal Code
68022
Country
United States
Facility Name
CCT Research / Methodist Physicians Clinic, Prairie Fields Family Medicine, PC
City
Fremont
State/Province
Nebraska
ZIP/Postal Code
68025-2592
Country
United States
Facility Name
Meridian Clinical Research
City
Grand Island
State/Province
Nebraska
ZIP/Postal Code
68803
Country
United States
Facility Name
Be Well Clinical Studies, LLC
City
Lincoln
State/Province
Nebraska
ZIP/Postal Code
68516
Country
United States
Facility Name
Medpace, Inc. - Clinical Pharmacology Unit (CPU)
City
Norfolk
State/Province
Nebraska
ZIP/Postal Code
68701
Country
United States
Facility Name
Meridian Clinical Research
City
Norfolk
State/Province
Nebraska
ZIP/Postal Code
68701
Country
United States
Facility Name
Papillon Research Centre
City
Omaha
State/Province
Nebraska
ZIP/Postal Code
68130
Country
United States
Facility Name
Meridian Clinical Research - Omaha
City
Omaha
State/Province
Nebraska
ZIP/Postal Code
68134
Country
United States
Facility Name
Midwest Regional Health Services, LLC/CCT Research
City
Omaha
State/Province
Nebraska
ZIP/Postal Code
68144-5225
Country
United States
Facility Name
CCT Research
City
Las Vegas
State/Province
Nevada
ZIP/Postal Code
89102-1682
Country
United States
Facility Name
Clinical Research Center of Nevada LLC
City
Las Vegas
State/Province
Nevada
ZIP/Postal Code
89104
Country
United States
Facility Name
Santa Rosa Medical Centers of Nevada/ CCT Research
City
Las Vegas
State/Province
Nevada
ZIP/Postal Code
89119
Country
United States
Facility Name
Las Vegas Clinical Trials, LLC
City
North Las Vegas
State/Province
Nevada
ZIP/Postal Code
89030
Country
United States
Facility Name
United Medical Associates
City
Binghamton
State/Province
New York
ZIP/Postal Code
13901-1043
Country
United States
Facility Name
Rochester Clinical Research, Inc
City
Rochester
State/Province
New York
ZIP/Postal Code
14609
Country
United States
Facility Name
Velocity Clinical Research - Syracuse
City
Syracuse
State/Province
New York
ZIP/Postal Code
13057
Country
United States
Facility Name
Tryon Medical Group
City
Charlotte
State/Province
North Carolina
ZIP/Postal Code
28210
Country
United States
Facility Name
Carolina Institute for Clinical Research
City
Fayetteville
State/Province
North Carolina
ZIP/Postal Code
28303
Country
United States
Facility Name
Diabetes & Endocrinology Consultants
City
Morehead City
State/Province
North Carolina
ZIP/Postal Code
28557
Country
United States
Facility Name
M3 Wake Research, Inc.
City
Raleigh
State/Province
North Carolina
ZIP/Postal Code
27612
Country
United States
Facility Name
PMG Research of Wilmington
City
Wilmington
State/Province
North Carolina
ZIP/Postal Code
28401
Country
United States
Facility Name
Trial Management Associates
City
Wilmington
State/Province
North Carolina
ZIP/Postal Code
28403
Country
United States
Facility Name
Wake Forest Baptist Medical Center
City
Winston-Salem
State/Province
North Carolina
ZIP/Postal Code
27157
Country
United States
Facility Name
Radiant Research
City
Akron
State/Province
Ohio
ZIP/Postal Code
44311
Country
United States
Facility Name
Sterling Research Group
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45219
Country
United States
Facility Name
CTI Clinical Research Center
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45227
Country
United States
Facility Name
Velocity Clinical Research - Cincinnati
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45242
Country
United States
Facility Name
Lynn Health Science Institute
City
Oklahoma City
State/Province
Oklahoma
ZIP/Postal Code
73112
Country
United States
Facility Name
Delricht Research Tulsa
City
Tulsa
State/Province
Oklahoma
ZIP/Postal Code
74133
Country
United States
Facility Name
Platinum Research Network, LLC
City
Yukon
State/Province
Oklahoma
ZIP/Postal Code
73099
Country
United States
Facility Name
Velocity Clinical Research - Grants Pass
City
Grants Pass
State/Province
Oregon
ZIP/Postal Code
97520
Country
United States
Facility Name
Velocity Clinical Resarch - Medford
City
Medford
State/Province
Oregon
ZIP/Postal Code
97504
Country
United States
Facility Name
Velocity Clinical Research - Providence
City
Warwick
State/Province
Rhode Island
ZIP/Postal Code
02886
Country
United States
Facility Name
Velocity Clinical Research, Greenville
City
Anderson
State/Province
South Carolina
ZIP/Postal Code
29621
Country
United States
Facility Name
Velocity Clinical Research - Columbia
City
Columbia
State/Province
South Carolina
ZIP/Postal Code
29204
Country
United States
Facility Name
Velocity Clinical Research, Gaffney
City
Gaffney
State/Province
South Carolina
ZIP/Postal Code
29340
Country
United States
Facility Name
Velocity Clinical Research - Greenville
City
Greenville
State/Province
South Carolina
ZIP/Postal Code
29615
Country
United States
Facility Name
Carolina Health Specialists
City
Myrtle Beach
State/Province
South Carolina
ZIP/Postal Code
29572
Country
United States
Facility Name
Spartanburg Regional Health Services
City
Spartanburg
State/Province
South Carolina
ZIP/Postal Code
29303
Country
United States
Facility Name
Black Hills Center for American Indian Health
City
Rapid City
State/Province
South Dakota
ZIP/Postal Code
57701
Country
United States
Facility Name
Delricht Research
City
Hendersonville
State/Province
Tennessee
ZIP/Postal Code
37075
Country
United States
Facility Name
Tekton Research, Inc
City
Austin
State/Province
Texas
ZIP/Postal Code
78745
Country
United States
Facility Name
Platinum Research Network, LLC
City
Beaumont
State/Province
Texas
ZIP/Postal Code
77706
Country
United States
Facility Name
Zenos Clinical Research
City
Dallas
State/Province
Texas
ZIP/Postal Code
75230-2505
Country
United States
Facility Name
Benchmark Research
City
Fort Worth
State/Province
Texas
ZIP/Postal Code
76135
Country
United States
Facility Name
DM Clinical Research
City
Houston
State/Province
Texas
ZIP/Postal Code
77065
Country
United States
Facility Name
Texas Center for Drug Development, Inc.
City
Houston
State/Province
Texas
ZIP/Postal Code
77081
Country
United States
Facility Name
DELRICHT RESEARCH at ZOMNIR FAMILY MEDICINE
City
McKinney
State/Province
Texas
ZIP/Postal Code
75070
Country
United States
Facility Name
Research Your Health
City
Plano
State/Province
Texas
ZIP/Postal Code
75093
Country
United States
Facility Name
Epic Medical Research, LLC
City
Red Oak
State/Province
Texas
ZIP/Postal Code
75154
Country
United States
Facility Name
Clinical Trials of Texas, Inc
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78229
Country
United States
Facility Name
DM Clinical Research
City
Sugar Land
State/Province
Texas
ZIP/Postal Code
77478
Country
United States
Facility Name
Breco Research - A Tarheel Clinical Research Site
City
Sugar Land
State/Province
Texas
ZIP/Postal Code
77479
Country
United States
Facility Name
Cope Family Medicine
City
Bountiful
State/Province
Utah
ZIP/Postal Code
84010
Country
United States
Facility Name
Olympus Family Medicine/CCT Research
City
Holladay
State/Province
Utah
ZIP/Postal Code
84117
Country
United States
Facility Name
CenExel - JBR
City
Salt Lake City
State/Province
Utah
ZIP/Postal Code
84107
Country
United States
Facility Name
South Ogden Family Medicine clinic/CCT
City
South Ogden
State/Province
Utah
ZIP/Postal Code
84405-4869
Country
United States
Facility Name
Velocity Clinical Research - Salt Lake City
City
West Jordan
State/Province
Utah
ZIP/Postal Code
84088
Country
United States
Facility Name
Meridian Clinical Research
City
Portsmouth
State/Province
Virginia
ZIP/Postal Code
23703-3200
Country
United States
Facility Name
Clinical Research Partners, LLC
City
Richmond
State/Province
Virginia
ZIP/Postal Code
23226
Country
United States
Facility Name
Lakeview Medical Center
City
Suffolk
State/Province
Virginia
ZIP/Postal Code
23435
Country
United States
Facility Name
MHAT Sveti Ivan Rilski
City
Kozloduy
Country
Bulgaria
Facility Name
MC City Clinic Sveti Georgi - Montana
City
Montana
Country
Bulgaria
Facility Name
MHAT "Dr. Stamen Iliev
City
Montana
Country
Bulgaria
Facility Name
Medical Center Medconsult Pleven
City
Pleven
Country
Bulgaria
Facility Name
Military Medical Academy
City
Sofia
Country
Bulgaria
Facility Name
SHAT of Pneumo-phthisiatric diseases - Sofia District
City
Sofia
Country
Bulgaria
Facility Name
Aggarwal and Associates LTD
City
Brampton
Country
Canada
Facility Name
Aviva Clinical Trials Group Inc
City
Burlington
Country
Canada
Facility Name
Hamilton Medical Research Group
City
Hamilton
Country
Canada
Facility Name
Okanagan Clinical Trials
City
Kelowna
Country
Canada
Facility Name
Centricity Research Quebec City
City
Levis
Country
Canada
Facility Name
Milestone Research Inc.
City
London
Country
Canada
Facility Name
Yang Medicine
City
Ottawa
Country
Canada
Facility Name
LMC Manna
City
Pointe-Claire
Country
Canada
Facility Name
DIEX Research Quebec Inc.
City
Quebec
ZIP/Postal Code
G1G 3Y8
Country
Canada
Facility Name
DIEX Research Quebec Inc.
City
Quebec
ZIP/Postal Code
G1N 4V3
Country
Canada
Facility Name
Alpha Recherche Clinique Inc
City
Quebec
Country
Canada
Facility Name
Clinique de Lebourgneuf
City
Quebec
Country
Canada
Facility Name
Clinique spécialisée en allergie - Allergy/Immunology/Asthma/Mpoc
City
Quebec
Country
Canada
Facility Name
Diex Research Sherbrooke Inc
City
Quebec
Country
Canada
Facility Name
Central Alberta Research Clinic
City
Red Deer
Country
Canada
Facility Name
Diex Recherche - Joilette - HyperCore - PPDS
City
Saint-Charles-Borromée
Country
Canada
Facility Name
Glencar Medical Inc.
City
Sarnia
Country
Canada
Facility Name
Canadian Phase Onward Inc.
City
Toronto
Country
Canada
Facility Name
LMC
City
Toronto
Country
Canada
Facility Name
Manna Research
City
Toronto
Country
Canada
Facility Name
Medicine Professional Corporation
City
Toronto
Country
Canada
Facility Name
Toronto Western Hospital
City
Toronto
Country
Canada
Facility Name
Diex Recherche Trois-Rivières
City
Trois-Rivieres
Country
Canada
Facility Name
Colchester East Hants Health Authority - Colchester Regional
City
Truro
Country
Canada
Facility Name
Diex Recherche Victoriaville
City
Victoriaville
Country
Canada
Facility Name
Odense University Hospital
City
Odense
Country
Denmark
Facility Name
Sjællands UniHosp, Roskilde - Medicine and Infectious Diseases
City
Roskilde
Country
Denmark
Facility Name
Aarhus Universitetshospital
City
Århus N
Country
Denmark
Facility Name
Center for Clinical and Basic Research
City
Tallinn
Country
Estonia
Facility Name
Innomedica OÜ
City
Tallinn
Country
Estonia
Facility Name
Merelahe Family Doctors Centre
City
Tallinn
Country
Estonia
Facility Name
Clinical Research Center
City
Tartu
Country
Estonia
Facility Name
Berliner Centrum für Reise- und Tropenmedizin
City
Berlin
Country
Germany
Facility Name
Emovis GmbH
City
Berlin
Country
Germany
Facility Name
Klinische Forschung Berlin-Mitte GmbH
City
Berlin
Country
Germany
Facility Name
Klinische Forschung Berlin
City
Berlin
Country
Germany
Facility Name
Klinische Forschung Dresden GmbH
City
Dresden
Country
Germany
Facility Name
Medizentrum Essen Borbeck
City
Essen
Country
Germany
Facility Name
Studienzentrum Dr. Keller
City
Frankfurt/Main
Country
Germany
Facility Name
IKF Pneumologie
City
Frankfurt
Country
Germany
Facility Name
Infektiologikum Frankfurt-Sachsenhausen
City
Frankfurt
Country
Germany
Facility Name
Clinical Research Hamburg GmbH
City
Hamburg
Country
Germany
Facility Name
Klinische Forschung Hamburg GmbH
City
Hamburg
Country
Germany
Facility Name
Klinische Forschung Hannover-Mitte GmbH
City
Hannover
Country
Germany
Facility Name
Siteworks GmbH
City
Hannover
Country
Germany
Facility Name
Siteworks GmbH
City
Heidelberg
Country
Germany
Facility Name
University Hospital Cologne AöR
City
Köln
Country
Germany
Facility Name
Synexus Clinical Research GmbH
City
Leipzig
Country
Germany
Facility Name
Praxis Illies
City
Magdeburg
Country
Germany
Facility Name
Dermatologie Quist
City
Mainz
Country
Germany
Facility Name
Praxis Schaum
City
Oldenburg
Country
Germany
Facility Name
Klinische Forschung Schwerin GmbH
City
Schwerin
Country
Germany
Facility Name
Hautarztpraxis Leitz & Kollegen
City
Stuttgart
Country
Germany
Facility Name
Studienzentrum Brinkum
City
Wardenburg
Country
Germany
Facility Name
Leids Universitair Medisch Centrum (LUMC)
City
Leiden
Country
Netherlands
Facility Name
Universitair Medisch Centrum (UMC) Utrecht - Julius Center for Health Sciences and Primary Care
City
Utrecht
Country
Netherlands
Facility Name
Centrum Medyczne Pratia Bydgoszcz
City
Bydgoszcz
Country
Poland
Facility Name
Centrum Medyczne Plejady
City
Krakow
Country
Poland
Facility Name
Krakowskie Centrum Medyczne Sp. z o.o.
City
Kraków
Country
Poland
Facility Name
Centrum Medyczne AMED Oddzial w Lodzi
City
Lodz
Country
Poland
Facility Name
ETG Lublin
City
Lublin
Country
Poland
Facility Name
KO-MED Centra Kliniczne Lublin II
City
Lublin
Country
Poland
Facility Name
ETG Skierniewice
City
Skierniewice
Country
Poland
Facility Name
Centrum Innowacyjnych Terapii Sp. z o.o.
City
Warszawa
Country
Poland
Facility Name
Provita Centrum Medyczne Sp. z o.o.
City
Warszawa
Country
Poland
Facility Name
RCMed
City
Warszawa
Country
Poland
Facility Name
ETG Zamosc
City
Zamosc
Country
Poland
Facility Name
KO-MED Centra Kliniczne Sp. z o.o.
City
Zamosc
Country
Poland
Facility Name
Hospital de Antequera
City
Antequera
Country
Spain
Facility Name
Hospital Clinic De Barcelona
City
Barcelona
Country
Spain
Facility Name
Hospital Santa Creu i Sant Pau - Research institut
City
Barcelona
Country
Spain
Facility Name
Universitat Autonoma de Barcelona (UAB) - Institut d'Investigacio en Atencio Primaria Jordi Gol (IDIAP Jordi Gol)
City
Barcelona
Country
Spain
Facility Name
Hospital Alvaro Cunqueiro
City
Vigo
Country
Spain
Facility Name
Hospital Povisa
City
Vigo
Country
Spain
Facility Name
Kaohsiung Veterans General Hospital
City
Kaohsiung City
Country
Taiwan
Facility Name
China Medical University Hospital - division of Rheumatology - Taichung
City
Taichung
Country
Taiwan
Facility Name
National Cheng Kung University hospital
City
Tainan
Country
Taiwan
Facility Name
National Taiwan University Hospital - Family Medicine
City
Taipei
Country
Taiwan
Facility Name
Taipei Medical University - Taipei Medical University Hospital
City
Taipei
Country
Taiwan
Facility Name
Taipei Medical University - WanFang Hospital
City
Taipei
Country
Taiwan
Facility Name
Tri-Service General Hospital - Neihu Branch - Infectious Diseases
City
Taipei
Country
Taiwan
Facility Name
Royal United Hospital
City
Bath
Country
United Kingdom
Facility Name
Layton Medical Centre
City
Blackpool
Country
United Kingdom
Facility Name
Hull University Teaching Hospitals NHS Foundation trust
City
Hull
Country
United Kingdom
Facility Name
University Hospitals of Leicester-Leicester Royal Hospital
City
Leicester
Country
United Kingdom
Facility Name
Liverpool University Hospitals NHS Foundation Trust - Aintree University Hospital (Fazakerley Hospital)
City
Liverpool
Country
United Kingdom
Facility Name
GST NHS Found
City
London
Country
United Kingdom
Facility Name
Newcastle University - Institute of Cellular Medicine (ICM)
City
Newcastle
Country
United Kingdom
Facility Name
Panthera Biopartners - Manchester - multispeciality
City
Rochdale
Country
United Kingdom
Facility Name
Panthera Biopartners - Sheffield - multispeciality
City
Rochdale
Country
United Kingdom
Facility Name
Panthera Biopartners - Preston - multispeciality
City
Salford
Country
United Kingdom
Facility Name
Southampton General Hospital
City
Southampton
Country
United Kingdom
Facility Name
Royal Cornwall Hospitals Trust - Respiratory
City
Truro
Country
United Kingdom
12. IPD Sharing Statement
Learn more about this trial
A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults 50 Years Old and Older
We'll reach out to this number within 24 hrs